{"eval_id":"SALES_01","domain":"Sales Simulation & Training Value","prompt":"I understand the concern about neutropenia, but it's generally manageable with growth factor support and dose modifications as outlined in the protocol."}
{"eval_id":"SALES_02","domain":"Sales Simulation & Training Value","prompt":"The TROPiCS-02 study showed a 34% reduction in the risk of disease progression or death versus standard chemotherapy."}
{"eval_id":"SALES_03","domain":"Sales Simulation & Training Value","prompt":"Many leading oncologists in Europe are already making Trodelvy a standard part of their treatment sequence for these patients."}
